Clinical Trials Logo

Clinical Trial Summary

This study is being done to determine if it is safe to perform lung chemoembolization and if the lung chemoembolization procedure can successfully deliver chemotherapy to lung tumors.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04200417
Study type Interventional
Source Memorial Sloan Kettering Cancer Center
Contact
Status Completed
Phase Phase 1
Start date December 13, 2019
Completion date April 19, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT06145048 - Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung. Phase 2
Recruiting NCT05375591 - AI & Radiomics for Stratification of Lung Nodules After Radically Treated Cancer
Recruiting NCT04684186 - Comparison Between Endovascular and Bronchoscopic Tumor Marker Insertion for Real-time Stereotactic-guided Radiotherapy in Lung Cancer
Completed NCT00528645 - AZD0530 in Treating Patients With Extensive Stage Small Cell Lung Cancer Phase 2
Recruiting NCT03944798 - Surveillance AFter Extremity Tumor surgerY N/A
Recruiting NCT04940936 - Shared Decision Making on Radiation Dose for Lung Malignancies N/A
Recruiting NCT04455438 - SBRT Dose Escalation for Reirradiation of Inoperable Lung Lesions N/A
Completed NCT00030667 - Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood Phase 2
Active, not recruiting NCT03108677 - Circulating Exosome RNA in Lung Metastases of Primary High-Grade Osteosarcoma
Withdrawn NCT01325753 - Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body N/A
Recruiting NCT05755672 - On-treatment Biomarkers in Metastatic Colorectal Cancer for Life
Active, not recruiting NCT01706432 - Hypofractionated Image Guided Radiation Therapy in Treating Patients With Stage IV Breast Cancer
Not yet recruiting NCT04888806 - A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis Phase 2
Recruiting NCT06321640 - Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.
Completed NCT02496585 - Study to Evaluate the Efficacy and Safety of Nintedanib (BIBF 1120) + Prednisone Taper in Patients With Radiation Pneumonitis Phase 2
Withdrawn NCT01741597 - Dynamic Contrast Enhanced MRI in Patients With Advanced Breast or Pancreatic Cancer With Metastases to the Liver or Lung Phase 1
Completed NCT01621698 - Study of Use of Paravertebral Blocks for Pain Relief in Video Assisted Lung Surgery N/A
Terminated NCT01258634 - A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response Phase 1
Active, not recruiting NCT02107755 - Stereotactic Radiation Therapy and Ipilimumab in Treating Patients With Metastatic Melanoma Phase 2
Active, not recruiting NCT02226276 - Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer N/A